JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility
- 1 September 2006
- journal article
- review article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 8 (4) , 397-411
- https://doi.org/10.2353/jmoldx.2006.060007
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- JAK2 V617F in myeloid disorders: What do we know now, and where are we headed?Leukemia & Lymphoma, 2006
- bcr/abl-Negative, Classic Myeloproliferative Disorders: Diagnosis and TreatmentMayo Clinic Proceedings, 2005
- Red cell mass and plasma volume measurements in polycythemia:Cancer, 2005
- Essential thrombocythaemia: challenges and evidence‐based managementBritish Journal of Haematology, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disordersPathologie Biologie, 2004
- Diagnosis of the myeloproliferative disorders: Resolving phenotypic mimicrySeminars in Hematology, 2003
- Detection of single-base mutations in a mixed population of cells: A comparison of SSCP and direct sequencingGenetic Analysis: Biomolecular Engineering, 1992
- Chromosome Studies in 104 Patients With Polycythemia VeraMayo Clinic Proceedings, 1991